Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2023-09-20
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Exploratory Study of Visual Function Rehabilitation in Patients With Ocular Trauma
NCT06174415
Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD
NCT04676854
Image Biomarkers for Progression of AMD
NCT04537143
Heidelberg In Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals
NCT04025801
Research on a New Intelligent Mobile Screening and Diagnosis Pattern for Ocular Diseases
NCT07003165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental group
high-frequency multi-band harmonic electromagnetic stimulation device group
BOBY
high-frequency multi-band harmonic electromagnetic stimulation device
control group
placebo device group
Control
placebo group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BOBY
high-frequency multi-band harmonic electromagnetic stimulation device
Control
placebo group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* diabetes
* heart disease
* eye-related diseases
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chung Shan Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Central University
Hsinchu, Taiwan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202304EM005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.